Metoclopramide-induced tardive dyskinesia in an infant

Movement Disorders

Volumn 20, Issue 1, 2005, Pages 86-89

  Mejia, Nicte I ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Infant; Metoclopramide; Neuroleptic drugs; Tardive dyskinesia

Indexed keywords

METOCLOPRAMIDE; RANITIDINE;

ANAMNESIS; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INSOMNIA; IRRITABILITY; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; MALE; METOCLOPRAMIDE; STEREOTYPED BEHAVIOR;

EID: 14044261313     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20259     Document Type: Article

References (27)

1. Putnam PE, Orenstein SR, Wessel HB, Stowe RM. Tardive dyskinesia associated with use of metoclopramide in a child. J Pediatr 1992;121:983-985.
2. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995;18:197-214.
3. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesia. Neurology 1993;43: 937-941.
4. Armenteros JL, Adams PB, Campbell M, Eisenberg ZW. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 1995;31:363-369.
5. Bharucha KJ, Sethi KD. Tardive tourettism after exposure to neuroleptic therapy. Mov Disord 1995;10:791-793.
6. Browning DH, Ferry PC. Tardive dyskinesia in a ten-year-old boy. Clin Pediatr 1976;15:955-957.
7. Caine ED, Margolin DI, Brown GL, Ebert MH. Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. Am J Psychiatry 1978;135:241-242.
8. Caine ED, Polinsky RJ. Tardive dyskinesia in persons with Gilles de la Tourette's Disease. Arch Neurol 1981;38:471-472.
9. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 1997;36:835-843.
10. Gualtieri CT, Barnhill J, McGimsey J, Schell D. Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs. J Am Acad Child Adolesc Psychiatry 1980;19:491-510.
11. Gualtieri CT, Schroeder SR, Hicks RE, Quade D. Tardive dyskinesia in young mentally retarded individuals. Arch Gen Psychiatry 1986;43:335-340.
12. Kumra S, Jacobsen LK, Lenane M, et al. Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1998;37:221-227.
13. MacEwan TH, Morton MJS. Use of clozapine in a child with treatment-resistalft schizophrenia. Br J Psychiatry 1996;168:376-378.
14. McAndrew JB, Case Q, Treffert DA. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. J Autism Childhood Schizophrenia 1972;2:14-91.
15. McLean P, Casey DE. Tardive dyskinesia in an adolescent. Am J Psychiatry 1978;135:969-971.
16. Mizrahi EM, Holtzman D, Tharp B. Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease. Arch Neurol 1980;37:780.
17. Paulson GW, Rizvi CA, Crane GE. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines. Clin Pediatr 1975;14:953-955.
18. Singh SK, Jankovic J. Tardive dystonia in patients with Tourette's syndrome. Mov Disord 1988;3:274-280.
19. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989;149:2486-2492.
20. Sewell DD, Kodsi AB, Caligiuri MP, Jeste DV. Metoclopramide and tardive dyskinesia. Biol Psychiatry 1994;36:630-632.
21. Tan A, Salgado M, Fahn S. The characterization and outcome of stereotypic movements in nonautistic children. Mov Disord 1997; 12:47-52.
22. Castellanos FX, Ritchie GF, Marsh WL, Rapoport JL. DSM-IV stereotypic movement disorder: persistence of stereotypies of infancy in intellectually normal adolescents and adults. J Clin Psychiatry 1996;57:116-122.
23. Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J 1990; 83:525-532.
24. Connor DF, Fletcher KE, Wood JS. Neuroleptic-related dyskinesias in children and adolescents. J Clin Psychiatry 2001;62:967-974.
25. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48:358-362.
26. Vuong KD, Hunter CB, Mejia N, Jankovic J. Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders. Mov Disord (in press).
27. Chatterjee A, Frucht SJ. Tetrabenazine in the treatment of severe pediatric chorea. Mov Disord 2003;18:703-706.